CoChat

The Androgen Metabolite, 5α-Androstane-3β, 17β-Diol, Is a Potent Modulator of Estrogen Receptor-β1-Mediated Gene Transcription in Neuronal Cells

Pak, Toni R., Chung, Wilson C. J., Lund, Trent D., Hinds, Laura R., Clay, Colin M., Handa, Robert J. · 2005 · Endocrinology
Cited by 141

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

5α-Androstane-3β, 17β-diol (3βAdiol) is a metabolite of the potent androgen, 5α-dihydrotestosterone. Recent studies showed that 3βAdiol binds to estrogen receptor (ER)-β and regulates growth of the prostate gland through an estrogen, and not androgen, receptor-mediated pathway. These data raise the possibility that 3βAdiol could regulate important physiological processes in other tissues that produce 3βAdiol, such as the brain. Although it is widely accepted that the brain is a target for 5α-dihydrotestosterone action, there is no evidence that 3βAdiol has a direct action in neurons. To explore the molecular mechanisms by which 3βAdiol might act to modulate gene transcription in neuronal cells, we examined whether 3βAdiol activates ER-mediated promoter activity and whether ER transactivation is facilitated by a classical estrogen response element (ERE) or an AP-1 complex. The HT-22 neuronal cell line was cotransfected with an expression vector containing ERα, ER-β1, or the ERβ splice variant, ER-β2 and one of two luciferase-reporter constructs containing either a consensus ERE or an AP-1 enhancer site. Cells were treated with 100 nm 17β-estradiol, 100 nm 3βAdiol, or vehicle for 15 h. We show that 3βAdiol activated ER-β1-induced transcription mediated by an ERE equivalent to that of 17β-estradiol. By contrast, 3βAdiol had no effect on ERα- or ER-β2-mediated promoter activity. Moreover, ER-β1 stimulated transcription mediated by an ERE and inhibited transcription by an AP-1 site in the absence of ligand binding. These data provide evidence for activation of ER signaling pathways by an androgen metabolite in neuronal cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2004-0871

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 36

  1. Grover, 1975, Correlation of in vivo and in vitro activities of some naturally occurring androgens using a radioreceptor assay for 5α-dihydrotestosterone with rat prostate cytosol receptor protein., J Steroid Biochem, 6, 1373, 10.1016/0022-4731(75)90072-2 · DOI
  2. Ahmad, 1978, The effects of 5α-reduced androgens on maintenance and regeneration of prostate glands and seminal vesicles in castrated and hypophysectomized rats., Anat Rec, 192, 543, 10.1002/ar.1091920408 · doi:10.1002/ar.1091920408
  3. Weihua, 2002, An endocrine pathway in the prostate, ERβ, AR, 5α-androstane-3β, 17β-diol, and CYP7B1 regulates prostate growth., Proc Natl Acad Sci USA, 99, 13589, 10.1073/pnas.162477299 · DOI · Paper page
  4. Torn, 2003, Production, purification, and functional analysis of recombinant human and mouse 17β-hydroxysteroid dehydrogenase type 7., Biochem Biophys Res Commun, 305, 37, 10.1016/S0006-291X(03)00694-6 · DOI
  5. Pelletier, 1995, Immunocytochemical localization of type I 17-β hydroxysteroid dehydrogenase in the rat brain., Brain Res, 704, 233, 10.1016/0006-8993(95)01119-6 · DOI
  6. Ibanez, 2003, Developmental expression of genes involved in neurosteroidogenesis: 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase in the rat brain., Endocrinology, 144, 2902, 10.1210/en.2002-0073 · DOI · Paper page
  7. Kuiper, 1997, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β., Endocrinology, 138, 863, 10.1210/endo.138.3.4979 · DOI · Paper page
  8. Petersen, 1998, Identification of estrogen receptor β2, a functional variant of estrogen receptor β expressed in normal rat tissues., Endocrinology, 139, 1082, 10.1210/endo.139.3.5840 · DOI · Paper page
  9. Hanstein, 1999, Functional analysis of a novel estrogen receptor-β isoform., Mol Endocrinol, 13, 129
  10. Price Jr, 2000, Differential expression of estrogen receptor β splice variants in rat brain: identification and characterization of a novel variant missing exon 4., Mol Brain Res, 80, 260, 10.1016/S0169-328X(00)00135-2 · DOI
  11. Kumar, 1988, The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer., Cell, 55, 145, 10.1016/0092-8674(88)90017-7 · DOI · Paper page
  12. Klein-Hitpass, 1989, Specific binding of estrogen receptor to the estrogen response element., Mol Cell Biol, 9, 43, 10.1128/MCB.9.1.43 · DOI · Paper page
  13. Paech, 1997, Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites., Science, 277, 1508, 10.1126/science.277.5331.1508 · DOI · Paper page
  14. Kushner, 2000, Estrogen receptor pathways to AP-1., J Steroid Biochem Mol Biol, 74, 311, 10.1016/S0960-0760(00)00108-4 · DOI · Paper page
  15. Kim, 2001, Neuroprotective effects of estrogen against β-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells., Neurosci Lett, 302, 58, 10.1016/S0304-3940(01)01659-7 · DOI
  16. Handa, 1987, Effect of estrogen on androgen receptor dynamics in female rat pituitary., Endocrinology, 121, 84, 10.1210/endo-121-1-84 · DOI · Paper page
  17. McDonnell, 2002, Elucidation of the molecular mechanism of action of selective estrogen receptor modulators., Am J Cardiol, 90, 35, 10.1016/S0002-9149(01)02221-4 · DOI
  18. Price Jr, 2000, Expression of estrogen receptor-β protein and mRNA in the cerebellum of the rat., Neurosci Lett, 288, 115, 10.1016/S0304-3940(00)01221-0 · DOI
  19. Shughrue, 2001, Distribution of estrogen receptor β immunoreactivity in the rat central nervous system., J Comp Neurol, 436, 64, 10.1002/cne.1054 · DOI · Paper page
  20. Jakab, 2001, Estrogen receptor β immunoreactivity in differentiating cells of the developing rat cerebellum., J Comp Neurol, 430, 396, 10.1002/1096-9861(20010212)430:3<396::AID-CNE1039>3.0.CO;2-0 · DOI · Paper page
  21. Shang, 2000, Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription., Cell, 103, 843, 10.1016/S0092-8674(00)00188-4 · DOI · Paper page
  22. Feng, 1998, Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors., Science, 280, 1747, 10.1126/science.280.5370.1747 · DOI · Paper page
  23. Zhang, 1997, An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer., Cancer Res, 57, 1244
  24. Power, 1991, Dopaminergic and ligand-independent activation of steroid hormone receptors., Science, 254, 1636, 10.1126/science.1749936 · DOI · Paper page
  25. Ignar-Trowbridge, 1992, Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor., Proc Natl Acad Sci USA, 89, 4658, 10.1073/pnas.89.10.4658 · DOI · Paper page
  26. Klotz, 2002, Requirement of estrogen receptor-α in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk., J Biol Chem, 277, 8531, 10.1074/jbc.M109592200 · DOI · Paper page
  27. Schlegel, 2001, Ligand-independent activation of oestrogen receptor α by caveolin-1., Biochem J, 359, 203, 10.1042/bj3590203 · doi:10.1042/bj3590203
  28. Goff, 1994, Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity., J Biol Chem, 269, 4458, 10.1016/S0021-9258(17)41801-1 · DOI · Paper page
  29. Arnold, 1994, Serine 167 is the major estradiol-induced phosphorylation site on human estrogen receptor., Mol Endocrinol, 8, 1208
  30. Tremblay, 1999, Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1., Mol Cell, 3, 513, 10.1016/S1097-2765(00)80479-7 · DOI · Paper page
  31. Tremblay, 2001, Contribution of steroid receptor coactivator-1 and CREB binding protein in ligand-independent activity of estrogen receptor β., J Steroid Biochem Mol Biol, 77, 19, 10.1016/S0960-0760(01)00031-0 · DOI
  32. Webb, 1998, Estrogen receptor activation function 1 works by binding p160 coactivator proteins., Mol Endocrinol, 12, 1605, 10.1210/mend.12.10.0185 · doi:10.1210/mend.12.10.0185 · Paper page
  33. Murdoch, 1990, Estrogen receptor binding to a DNA response element in vitro is not dependent upon estradiol., Biochemistry, 29, 8377, 10.1021/bi00488a026 · DOI
  34. Webb, 1999, The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions., Mol Endocrinol, 13, 1672, 10.1210/mend.13.10.0357 · doi:10.1210/mend.13.10.0357 · Paper page
  35. Webb, 1995, Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens., Mol Endocrinol, 9, 443
  36. Tremblay, 1998, Ligand-independent activation of the estrogen receptors α and β by mutations of a conserved tyrosine can be abolished by antiestrogens., Cancer Res, 58, 877

Cited by

See all 141

Metadata

Authors
Pak, T. R., Chung, W. C. J., Lund, T. D., Hinds, L. R., Clay, C. M., & Handa, R. J.
Venue
Endocrinology
Published
2005-01-01
Volume
146
Issue
1
Pages
147-155
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2116654496
Cited by
141
References
10
FWCI
5.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Androgen Metabolite, 5α-Androstane-3β, 17β-Diol, Is a Potent Modulator of Estrogen Receptor-β1-Mediated Gene Transcription in Neuronal Cells. https://app.cochat.ai/papers/10.1210/en.2004-0871
The paper
Pak, T. R., Chung, W. C. J., Lund, T. D., Hinds, L. R., Clay, C. M., & Handa, R. J. (2005). The Androgen Metabolite, 5α-Androstane-3β, 17β-Diol, Is a Potent Modulator of Estrogen Receptor-β1-Mediated Gene Transcription in Neuronal Cells. Endocrinology. https://doi.org/10.1210/en.2004-0871

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.